San Francisco, California
London, United Kingdom
Network with VC and angel investors, learn about the current state of the market from active VCs and hear top entrepreneurs present.
Five Healthcare IT companies (Later stage Seed / Series A & B) will present.
Candidate companies MUST have raised a minimum of $500k outside (non founder) funding to be considered.
3:00 pm: Registration & networking
3:30 pm: VC Insight Panel
4:00 pm: Introduction to Georgetown Angels
4:15 pm: Five healthcare IT Startups
4:45 pm: Reception, Food & Networking
6:00 pm: Event close
VC Insight Panel
David Coats, Managing Director, Correlation Ventures
Richard Simoni, Partner, Asset Management Ventures
Stuart Collinson, Partner, Forward Ventures
|Edward van Wezel, Managing Partner, BioGeneration Ventures|
Special thanks to our sponsors:
Everyone that attends will get a 10% discount on their first Aranca 409a valuation and Dylan Gittleman, SVP Client Relations, will raffle 1 free 409a valuation.
Who Should Attend?
Angels & VCs interested in early stage companies
Entrepreneurs looking to network, learn and connect
Corporate Development professionals looking for partners & talent
Healthcare life science & tech / IT professionals encouraged to mingle & collaborate
Biotech, medical device, healthcare IT, healthcare services and non-healthcare technology professionals and investors welcome
Any person(s) receiving this email indirectly should contact Georgetown Angels
(email@example.com) for a proper invitation.
Events are not to be considered as General Soliticition as no forward looking financial statements nor investment opportunities will be discussed or presented.
All persons attending the event are subject to approval by Georgetown Angels and may be denied entrance based on inappropriate activity, actions or background
Georgetown Angels is a private venture capital company and is not associated or endorsed by Georgetown University. Angel investments involve a high degree of risk, and are only suitable for "accredited investors" as defined by the U.S. Securities and Exchange Commission. The information contained within this message is not an offer to purchase or solicitation to sell securities or any other financial instrument of any kind.
When & Where
Georgetown Angels is a VC fund combined with a premier angel investing group. We invest in later stage seed and series A & B venture capital financing rounds of technology startups. Our network of angels benefits both the companies we invest in and our members. Utilizing the collective contacts of our global angel network enables our portfolio companies access to capital and strategic relationships resulting in partnerships, talent, advisory boards, key customer introductions and leading venture capital firms for follow on funding. Our angel investors benefit from pooling deal flow, due diligence from relevant subject matter experts, capital, administrative resources and reporting and most of all adding value to our portfolio companies.
We are actively seeking additional angel investors from around the world to join our network. We enable angel investors to invest on a deal-by-deal basis. We believe sharing deal flow, due diligence and teaming up to back startups makes business sense for both investors and entrepreneurs. Our angel investors benefit from pooling deal flow, due diligence from relevant subject matter experts, capital, administrative resources and reporting and most of all adding value to our portfolio companies.